United States · FDA National Drug Code directory

risedronate sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 47335-928_a9910c38-e099-4f8a-a7e9-a88623be2032
Product NDC: 47335-928
Form: TABLET, FILM COATED
Composition / generic term: risedronate sodium
Labeler: Sun Pharmaceutical Industries, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20140611
Source listing expiry: 20271231

Source-listed ingredients

RISEDRONATE SODIUM HEMI-PENTAHYDRATE — 150 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BLISTER PACK in 1 CARTON (47335-928-60) / 1 TABLET, FILM COATED in 1 BLISTER PACK · 47335-928-60
3 BLISTER PACK in 1 CARTON (47335-928-67) / 1 TABLET, FILM COATED in 1 BLISTER PACK · 47335-928-67

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →